Correctional Managed Health Care
Infection Control Policy Manual
Policy # | Effective Date | Title | Format |
---|---|---|---|
06/2014 | Table of Contents | ||
11/2015 | Signature Page | ||
12/2016 | Signature Page | ||
11/2017 | Signature Page | ||
11/2018 | Signature Page | ||
06/11/2014 | Infection Control Committee Review Schedule | ||
01/14/2016 | Transmittal Memo | ||
04/06/2016 | Transmittal Memo | ||
06/03/2016 | Transmittal Memo | ||
09/29/2016 | Transmittal Memo | ||
10/11/2016 | Transmittal Memo | ||
12/06/2016 | Transmittal Memo | ||
03/20/2017 | Transmittal Memo | ||
04/03/2017 | Transmittal Memo | ||
04/26/2017 | Transmittal Memo | ||
06/01/2017 | Transmittal Memo | ||
11/27/2017 | Transmittal Memo | ||
06/26/2018 | Transmittal Memo | ||
12/05/2018 | Transmittal Memo | ||
B-14.01 | 02/08/2018 | Infection Control Program | |
B-14.02 | 02/08/2018 | Correctional Managed Health Care Infection Control Committee | |
B-14.03 | 02/08/2018 | Employee TB Testing | |
B-14.04 | 02/2018 | Prevention of Hepatitis B Virus (HBV) Infection in TDCJ Facilities | |
02/2018 | Attachments A-D: Hepatitis B Immunization | ||
B-14.05 | 02/2018 | Occupational Exposure Counseling and Testing for TDCJ and Correctional Managed Health Care Employees | |
08/2018 | Attachments A-N | ||
B-14.06 | 02/08/2018 | Management of Offender Bloodborne Exposures | |
B-14.07 | 04/2018 | Immunization | |
02/2017 | Attachments A-E | ||
04/2018 | Attachment F: Vaccine Adverse Event Reporting System | ||
Attachment: HPV Vaccine Gardasil® What You Need to Know - English | |||
Attachment: HPV Vaccine Gardasil® What You Need to Know - Spanish | |||
Attachment: Tetanus & Diphtheria Vaccine (Td) – English | |||
Attachment: Tetanus & Diphtheria Vaccine (Td) – Spanish | |||
B-14.10 | 10/2018 | Tuberculosis | |
Attachment G: Tuberculosis Elimination Division Report Contacts | |||
Attachment H Page 1: TB Program Evaluation | |||
Attachment H Page 2: Continuation of Report of Contacts | |||
B-14.11 ** | 02/2018 | Human Immunodeficiency Virus (HIV) Infection | |
B-14.11 ** | 02/09/2017 | HIV Disease Management | Link |
B-14.12 | 04/12/2018 | Syphilis | |
B-14.13.1 | 04/12/2018 | Hepatitis A | |
B-14.13.2 | 04/12/2018 | Hepatitis B | |
B-14.13.3 ** | 05/2018 | Hepatitis C | |
B-14.14 | 04/2018 | Varicella (Chickenpox) and Herpes Zoster (Shingles) | |
Attachment A: Varicella/Shingles Reporting Form | |||
Attachment B: Obtaining Varicella Biologicals | |||
Attachment: Varicella and Shingles Flowchart | |||
B-14.15 | 04/12/2018 | Meningitis | |
B-14.16 | 04/12/2018 | Skin and Soft Tissue Infection (MRSA) | |
Attachment B: Staph Aureus Surveillance Reporting Form | |||
Skin Soft Tissue Infection Treatment | Link | ||
B-14.17 | 04/12/2018 | Vancomycin Resistant Enterococcus (VRE) | |
B-14.18 | 04/12/2018 | Clostridium Difficile | |
B-14.19 | 08/2018 | Disease Reporting | |
B-14.20 | 08/2018 | Standard Precautions | |
B-14.21 | 08/2018 | Transmission-Based Precautions | |
Appendix A | |||
B-14.22 | 08/2018 | Handwashing | |
B-14.23 | 08/2018 | Medical Supply Decontamination | |
B-14.24 | 08/2018 | Disposal of Sharps, Needles and Syringes | |
B-14.25 | 08/2018 | Special (Medical) Waste Management | |
B-14.26 | 08/2018 | Gastrointestinal Illness | |
Attachment: GI Log | |||
B-14.27 | 08/2018 | Bloodborne Pathogen Exposure Control Plan | |
B-14.31 | 10/2018 | Personal Protective Equipment and Other Protective Supplies | |
B-14.40 | 10/2018 | Infection Control in Dental Clinics and Dental Laboratories (Refer to the Dental Services Manual, B14.1 Infection Control in Dental Clinics and Dental Laboratories) |
|
B-14.41 | 10/2018 | Barber/Beauty Shop Personnel | |
B-14.42 | 10/2018 | Food Handlers | |
B-14.50 | 10/2018 | Housing and Job Restrictions | |
B-14.51 | 10/2018 | Influenza-Like Illness (ILI) | |
Attachments A-D: Influenza-Like Illness | |||
Attachment E: Influenza-Like Illness (ILI) Log | |||
B-15.01 | 10/2018 | Environmental Inspection | |
B-16.01 | 10/2018 | Kitchen Sanitation and Food Handlers | |
B-17.01 | 10/2018 | Ectoparasite Control |
** Policies B-14.11 and B-14.13.3 must also be approved through the CMHCC as well as the CMHC Infection Control Committee.